lifestyle.forkstofeet.com

Category: Globe Newswire

Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025

September 8, 2025
Kroll and StepStone Group Launch Private Credit Benchmarks

September 8, 2025
Alterity Therapeutics Raises A$20.0 million in Strategic Placement

September 8, 2025
Dianthus Therapeutics Announces Positive Data for Claseprubart (DNTH103) from the Phase 2 MaGic Trial in Generalized Myasthenia Gravis, Supporting Its Potential Best-In-Class Profile

September 8, 2025
CorMedix Announces Strategic Minority Investment in Talphera

September 8, 2025
Abivax Presents First Half 2025 Financial Results

September 8, 2025
Prospect Capital Corporation and Affiliate Complete $18 Million Investment in The Ridge

September 8, 2025
ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Alto Neuroscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

September 8, 2025
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

September 8, 2025
BlueGenesLab Expands Genetic Panel to Include Three New GLP-1–Related Genes

September 8, 2025